# Track Awesome Glp1 Updates Daily

Awesome resources around the GLP1 Receptor Agonist class of treatments. Sponsored by GLP1.Guide

[ğŸ  Home](/README.md) Â· [ğŸ” Search](https://www.trackawesomelist.com/search/) Â· [ğŸ”¥ Feed](https://www.trackawesomelist.com/glp1guide/awesome-glp1/rss.xml) Â· [ğŸ“® Subscribe](https://trackawesomelist.us17.list-manage.com/subscribe?u=d2f0117aa829c83a63ec63c2f&id=36a103854c) Â· [â¤ï¸  Sponsor](https://github.com/sponsors/theowenyoung) Â· [ğŸ˜º glp1guide/awesome-glp1](https://github.com/glp1guide/awesome-glp1) Â· â­ 0 Â· ğŸ·ï¸ Miscellaneous

[ Daily / [Weekly](/content/glp1guide/awesome-glp1/week/README.md) / [Overview](/content/glp1guide/awesome-glp1/readme/README.md) ]

## [Feb 20, 2024](/content/2024/02/20/README.md)

### ğŸ§‘â€ğŸ¤â€ğŸ§‘ Trials

*   [STEP1 Trial](https://www.nejm.org/doi/full/10.1056/NEJMoa2032183) (Semaglutide)
    *   [On ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03548935)
*   [Step2 Trial](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736\(21\)00213-0/abstract) (Semaglutide)
*   [SURMOUNT-1 Trial](https://www.nejm.org/doi/full/10.1056/NEJMoa2206038) (Tirzepatide)
*   [SURMOUNT-4 Trial](https://jamanetwork.com/journals/jama/fullarticle/2812936)